Mabpharm Limited focuses on the research and development (R&D) and industrialization of antibody drugs. Through laboratory research and continuous validation of production scales, we ensure the consistent and stable production of high-quality products. Mabpharm Limited always maintains dynamic alignment with global advanced access levels, continuously designs and establishes production facilities and lines in accordance with international advanced standards, and utilizes state-of-the-art production equipment.

• 
• 

We have established a comprehensive management system covering the entire process from drug R&D to production, ensuring effective control of all products from development to manufacturing. All production lines that have been put into operation comply with relevant Good Manufacturing Practices (GMP). We have established a comprehensive management system covering the entire process from drug R&D to production, ensuring effective control of all products from development to manufacturing. All production lines that have been put into operation comply with relevant Good Manufacturing Practices (GMP) requirements and have successfully passed inspections by the National Medical Products Administration (NMPA), Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) member countries multiple times.

• 
• 
• 
• 

We have established multiple production workshops equipped with state-of-the-art equipment. All key equipment is sourced from internationally renowned brands, ensuring compliance with production requirements for various liquid injections in vials, lyophilized powder injections, and prefilled syringes.

• 
• 
• 
• 

Rather than using single-use bioreactors, we prefer stainless steel bioreactors across all production lines. This approach reduces long-term costs associated with disposable materials and lowers the risk of product quality variations. By implementing effect cost control measures, we aim to lower production and operational costs, thereby enhancing product competitiveness. We prioritize technological innovation and process optimization, continuously introducing advanced production technologies and equipment to improve production efficiency and product quality.

• 
• 
• 
•